ACON Stock Performance and Moving Averages. In recent trading, Aclarion Inc (ACON) stock price has shown some volatility, fluctuating 1.65% over the last five trades and -62.30% o ...

Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help ...

(Nasdaq: ACON), a company specializing in cutting-edge healthcare technology, saw its stock price surge by +6.44%, reaching $0.0479 during Friday’s premarket trading session. The jump follows the ...

Aclarion, Inc. (ACON) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants 15.01.2025 / 15:21 CET/CEST The issuer is solely ...

Aclarion Inc (NASDAQ:ACON) shares are trading lower by 62.5% to $0.34 Monday morning after the company priced its public offering of 5.175 million units. Each unit includes one share of common ...

Comparatively, Aclarion has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Aclarion has a consensus price target of $1.30, indicating a potential upside of ...

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes ...

BROOMFIELD, CO - January 17, 2025 (NEWMEDIAWIRE) - Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary ...

Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...